Cognitive/personality pattern and triplet expansion size in adult myotonic dystrophy type 1 (DM1): CTG repeats, cognition and personality in DM1

被引:74
|
作者
Sistiaga, A. [1 ]
Urreta, T. [2 ]
Jodar, M. [3 ,4 ]
Cobo, A. M. [5 ]
Emparanza, J. [2 ]
Otaegui, D. [1 ]
Poza, J. J. [6 ]
Merino, J. J. [1 ]
Imaz, H. [7 ]
Marti-Masso, J. F. [6 ]
Lopez de Munain, A. [6 ]
机构
[1] Donostia Hosp, Expt Unit, San Sebastian 20014, Spain
[2] Donostia Hosp, Epidemiol Unit, San Sebastian 20014, Spain
[3] Univ Autonoma Barcelona, Hlth & Social Psychol Dept, E-08193 Barcelona, Spain
[4] Hosp Sabadell, E-08193 Barcelona, Spain
[5] Hop Marin, AP HP, Assoc Francaise Myopathies, Hendaye, France
[6] Donostia Hosp, Dept Neurol, San Sebastian 20014, Spain
[7] Donostia Hosp, Dept Psychiat, San Sebastian 20014, Spain
关键词
Dysexecutive function; genotype-phenotype correlation; myotonic dystrophy; paranoid traits; personality; trinucleotide repeat disease; MUSCULAR-DYSTROPHY; NEUROPSYCHOLOGICAL DEFICITS; NEUROMUSCULAR DISEASES; TRINUCLEOTIDE REPEAT; IMPAIRMENT; AMPLIFICATION; INTELLIGENCE; DYSFUNCTION; PROFILES; SLEEP;
D O I
10.1017/S0033291709990602
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background. Although central nervous system (CNS) involvement in adult myotonic dystrophy type I (DM1) was described long ago, the large number of variables affecting the cognitive and personality profile have made it difficult to determine the effect of DM1 on the brain. The aim of this study was to define the cognitive and personality patterns in adult DM1 patients, and to analyse the relationship between these clinical patterns and their association with the underlying molecular defect. Method. We examined 121 adult DM1 patients with confirmed molecular CTG repeat expansion and 54 control subjects using comprehensive neuropsychological tests and personality assessments with the Millon Clinical Multiaxial Inventory (MCMI)-II. We used a multiple linear regression model to assess the effect of each variable on cognition and personality adjusted to the remainders. Results. Patients performed significantly worse than controls in tests measuring executive function (principally cognitive inflexibility) and visuoconstructive ability. In the personality profile, some paranoid and aggressive traits were predominant. Furthermore, there was a significant negative correlation between the CTG expansion size and many of the neuropsychological and personality measures. The molecular defect also correlated with patients' daytime somnolence. Conclusions. Besides muscular symptomatology, there is significant CTG-dependent involvement of the CNS in adult DM1 patients. Our data indicate that the cognitive impairment predominantly affects the fronto-parietal lobe.
引用
收藏
页码:487 / 495
页数:9
相关论文
共 50 条
  • [31] Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2
    Vihola, Anna
    Bachinski, Linda L.
    Sirito, Mario
    Olufemi, Shodimu-Emmanuel
    Hajibashi, Shohrae
    Baggerly, Keith A.
    Raheem, Olayinka
    Haapasalo, Hannu
    Suominen, Tiina
    Holmlund-Hampf, Jeanette
    Paetau, Anders
    Cardani, Rosanna
    Meola, Giovanni
    Kalimo, Hannu
    Edstrom, Lars
    Krahe, Ralf
    Udd, Bjarne
    ACTA NEUROPATHOLOGICA, 2010, 119 (04) : 465 - 479
  • [32] Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2
    Vincenzo Romeo
    E. Pegoraro
    C. Ferrati
    F. Squarzanti
    G. Sorarù
    A. Palmieri
    P. Zucchetta
    L. Antunovic
    E. Bonifazi
    G. Novelli
    C. P. Trevisan
    M. Ermani
    R. Manara
    C. Angelini
    Journal of Neurology, 2010, 257 : 1246 - 1255
  • [33] Evolving Motivations: Patients' and Caregivers' Perceptions About Seeking Myotonic Dystrophy (DM1) and Huntington's Disease Care
    LaDonna, Kori A.
    Watling, Christopher J.
    Ray, Susan L.
    Piechowicz, Christine
    Venance, Shannon L.
    QUALITATIVE HEALTH RESEARCH, 2017, 27 (11) : 1727 - 1737
  • [34] Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2
    Romeo, Vincenzo
    Pegoraro, E.
    Ferrati, C.
    Squarzanti, F.
    Soraru, G.
    Palmieri, A.
    Zucchetta, P.
    Antunovic, L.
    Bonifazi, E.
    Novelli, G.
    Trevisan, C. P.
    Ermani, M.
    Manara, R.
    Angelini, C.
    JOURNAL OF NEUROLOGY, 2010, 257 (08) : 1246 - 1255
  • [35] Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic Dystrophy type 1 (DM1): A retrospective, cross sectional study
    Rossi, Salvatore
    Della Marca, Giacomo
    Ricci, Martina
    Perna, Alessia
    Nicoletti, Tommaso F.
    Brunetti, Valerio
    Meleo, Emiliana
    Calvello, Mariarosaria
    Petrucci, Antonio
    Antonini, Giovanni
    Bucci, Elisabetta
    Licchelli, Loretta
    Sancricca, Cristina
    Massa, Roberto
    Rastelli, Emanuele
    Botta, Annalisa
    Di Muzio, Antonio
    Romano, Sonia
    Garibaldi, Matteo
    Silvestri, Gabriella
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 399 : 118 - 124
  • [36] Alternative splicing alterations of Ca2+handling genes are associated with Ca2+signal dysregulation in myotonic dystrophy type 1 ( DM1) and type 2 ( DM2) myotubes
    Santoro, M.
    Piacentini, R.
    Masciullo, M.
    Bianchi, M. L. E.
    Modoni, A.
    Podda, M. V.
    Ricci, E.
    Silvestri, G.
    Grassi, C.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2014, 40 (04) : 464 - 476
  • [37] Myoblasts generated by lentiviral mediated MyoD transduction of myotonic dystrophy type 1 (DM1) fibroblasts can be used for assays of therapeutic molecules
    Larsen J.
    Pettersson O.J.
    Jakobsen M.
    Thomsen R.
    Pedersen C.B.
    Hertz J.M.
    Gregersen N.
    Corydon T.J.
    Jensen T.G.
    BMC Research Notes, 4 (1)
  • [38] DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice
    Guiraud-Dogan, Celine
    Huguet, Aline
    Gomes-Pereira, Mario
    Brisson, Edith
    Bassez, Guillaume
    Junien, Claudine
    Gourdon, Genevieve
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2007, 1772 (11-12): : 1183 - 1191
  • [39] Shank sign in myotonic dystrophy type-1 (DM-1)
    Pradhan, Sunil
    JOURNAL OF CLINICAL NEUROSCIENCE, 2007, 14 (01) : 27 - 32
  • [40] Natural Compound Boldine Lessens Myotonic Dystrophy Type 1 Phenotypes in DM1 Drosophila Models, Patient-Derived Cell Lines, and HSALR Mice
    Alvarez-Abril, Mari Carmen
    Garcia-Alcover, Irma
    Colonques-Bellmunt, Jordi
    Garijo, Raquel
    Perez-Alonso, Manuel
    Artero, Ruben
    Lopez-Castel, Arturo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)